GLP-1 Weight Loss Drugs and Breast Cancer Survival: Expert Insights
Recent observational data suggest that GLP-1 receptor agonists, primarily used for type 2 diabetes and obesity, are associated with improved survival rates and reduced recurrence in breast cancer patients. While ... Read More